share_log

博安生物:自願性公告度拉糖肽注射液(BA5101)在中國完成III期臨床試驗及計劃遞交上市申請

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTPHASE 3 CLINICAL TRIAL COMPLETED IN CHINA FORDULAGLUTIDE INJECTION (BA5101) AND BLA TO BE FILED

Hong Kong Stock Exchange ·  Mar 8 12:28

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.